Origin Therapeutics Holdings (XCNQ:ORIG) Gross-Profit-to-Asset % : 0.00% (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Origin Therapeutics Holdings's annualized Gross Profit for the quarter that ended in Jun. 2023 was C$0.00 Mil. Origin Therapeutics Holdings's average Total Assets over the quarter that ended in Jun. 2023 was C$3.28 Mil. Therefore, Origin Therapeutics Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 was 0.00%.

Origin Therapeutics Holdings Gross-Profit-to-Asset % Historical Data

The historical data trend for Origin Therapeutics Holdings's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Gross-Profit-to-Asset % Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Gross-Profit-to-Asset %

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Origin Therapeutics Holdings's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Gross-Profit-to-Asset % falls into.

Origin Therapeutics Holdings Gross-Profit-to-Asset % Calculation

Origin Therapeutics Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Sep. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Sep. 2022 )	/	( (Total Assets (A: Sep. 2021 )	+	Total Assets (A: Sep. 2022 ))	/ count )
	=	0	/	( (7.059	+	5.588)	/ 2 )
	=	0	/	6.3235
	=	0.00 %

Origin Therapeutics Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Jun. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	0	/	( (3.369	+	3.191)	/ 2 )
	=	0	/	3.28
	=	0.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Origin Therapeutics Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.